The Class II recall covers 3 dosages of clonidine transdermal patches made by Actavis Laboratories, with no adverse health ...
Morristown-based Alvogen Inc. announced two lots of a transdermal patch used for delivery of the synthetic opioid Fentanyl have been recalled because the patches inside some cartons may contain a ...
Credit: Alvogen, Inc. Fentanyl is an opioid agonist indicated for the management of severe or persistent pain in opioid-tolerant patients. At this time, Alvogen Inc has received 1 serious adverse ...
The Healthy @Reader's Digest on MSN
300,000 Cartons of Blood Pressure Medicine Recalled Nationwide for ‘Unapproved’ Formulation
Both the delivery system and cited defect are relatively unusual—here's what we know.
Objective: To summarize the pharmaceutics, pharmacokinetics, development, and clinical application of IONSYS, the fentanyl HCl patient-controlled iontophoretic transdermal system for the management of ...
Credit: Getty Images. TPU-006 is an investigational transdermal system containing dexmedetomidine. The Food and Drug Administration (FDA) has granted Fast Track designation to Teikoku Pharma’s TPU-006 ...
Transdermal GFR System (TGFR) is a first-in-kind product for point of care assessment of kidney function in patients with normal or impaired renal function The transdermal GFR (tGFR) methodology has ...
Alvogen, Inc. is voluntarily recalling one lot of Fentanyl Transdermal System 25 mcg/h transdermal patches to the consumer level. The reason for the recall is that there is a potential that patches ...
Philadelphia, US – Shire plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ) announced that its methylphenidate transdermal system (MTS), DAYTRANA TM demonstrated statistically significant reductions in the ...
Please provide your email address to receive an email when new articles are posted on . MediBeacon Inc. announced it received a breakthrough device designation from the FDA for the company’s ...
The US Food and Drug Administration (FDA) has approved donepezil transdermal system (Adlarity) for patients with mild, moderate, or severe Alzheimer's disease (AD), the manufacturer has announced.
The U.S. Food and Drug Administration classified a Teva Pharmaceuticals recall of about 300,133 clonidine transdermal patch ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results